| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Nephrology, Leiden University Hospital, Leiden, The Netherlands; and
Medical Research Council Immunochemistry Unit, Department of Biochemistry, Oxford University, Oxford, United Kingdom
We and others have demonstrated previously the occurrence of cC1qR/CaR, a receptor for the collagen-like stalks of complement component C1q, on endothelial cells. In the present study we investigated whether binding of C1q to endothelial cells resulted in enhancement of cytokine or chemokine production. HUVEC produced 82 ± 91 pg/ml of IL-8, 79 ± 113 pg/ml of IL-6, and 503 ± 221 pg/ml of monocyte chemoattractant peptide-1 (MCP-1) under basal conditions. Incubation with C1q resulted in a time- and dose-dependent up-regulation of IL-8 (1012 ± 43 pg/ml), IL-6 (392 ± 20 pg/ml), and MCP-1 (2450 ± 101 pg/ml). This production is dependent on de novo protein synthesis, as demonstrated by the detection of specific mRNA after C1q stimulation, and inhibition of peptide production in the presence of cycloheximide. The production of all factors was inhibited (69 ± 7%) by the collagenous fragments of C1q, while the C1q globular heads only induced 13 ± 11% inhibition. When HUVEC were incubated with C1q in the presence of aggregated IgM, enhanced production of IL-8 (2500 ± 422 pg/ml), IL-6 (997 ± 21 pg/ml), and MCP-1 (5343 ± 302 pg/ml) was found. Furthermore, F(ab')2 anti-calreticulin partially inhibited the production of IL-8, confirming at least the involvement of cC1qR/CaR. These experiments suggest that in an inflammatory response C1q not only is able to activate the complement pathway, but when presented in a proper fashion also might induce the production of factors that contribute to acute phase responses and recruitment of inflammatory cells.
This article has been cited by other articles:
|
|
 |
|
  E. Shagdarsuren, K. Bidzhekov, Y. Djalali-Talab, E. A. Liehn, M. Hristov, R. A. Matthijsen, W. A. Buurman, A. Zernecke, and C. Weber C1-Esterase Inhibitor Protects Against Neointima Formation After Arterial Injury in Atherosclerosis-Prone Mice Circulation, January 1, 2008; 117(1): 70 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhang, W. Wright, D. A. Bernlohr, S. W. Cushman, and X. Chen Alterations of the classic pathway of complement in adipose tissue of obesity and insulin resistance Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1433 - E1440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wehner, C. N. Morrell, T. Reynolds, E. R. Rodriguez, and W. M. Baldwin III Antibody and Complement in Transplant Vasculopathy Circ. Res., February 2, 2007; 100(2): 191 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Oroszlan, E. Herczenik, S. Rugonfalvi-Kiss, A. Roos, A. J Nauta, M. R Daha, I. Gombos, I. Karadi, L. Romics, Z. Prohaszka, et al. Proinflammatory changes in human umbilical cord vein endothelial cells can be induced neither by native nor by modified CRP Int. Immunol., June 1, 2006; 18(6): 871 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. L. Groeneveld, M. Oroszlan, R. T. Owens, M. C. Faber-Krol, A. C. Bakker, G. J. Arlaud, D. J. McQuillan, U. Kishore, M. R. Daha, and A. Roos Interactions of the Extracellular Matrix Proteoglycans Decorin and Biglycan with C1q and Collectins J. Immunol., October 1, 2005; 175(7): 4715 - 4723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Cadavid, Y. Bai, D. Dail, M. Hurd, K. Narayan, E. Hodzic, S. W. Barthold, and A. R. Pachner Infection and Inflammation in Skeletal Muscle from Nonhuman Primates Infected with Different Genospecies of the Lyme Disease Spirochete Borrelia burgdorferi Infect. Immun., December 1, 2003; 71(12): 7087 - 7098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Kaplan, S. K. O'Neill, T. Koreny, M. Czipri, and A. Finnegan Development of Inflammation in Proteoglycan-Induced Arthritis Is Dependent on Fc{gamma}R Regulation of the Cytokine/Chemokine Environment J. Immunol., November 15, 2002; 169(10): 5851 - 5859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Feng, M. G. Tonnesen, E. I. B. Peerschke, and B. Ghebrehiwet Cooperation of C1q Receptors and Integrins in C1q-Mediated Endothelial Cell Adhesion and Spreading J. Immunol., March 1, 2002; 168(5): 2441 - 2448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kjaergaard, L. Peng, P. A. Cohen, J. A. Drazba, A. D. Weinberg, and S. Shu Augmentation Versus Inhibition: Effects of Conjunctional OX-40 Receptor Monoclonal Antibody and IL-2 Treatment on Adoptive Immunotherapy of Advanced Tumor J. Immunol., December 1, 2001; 167(11): 6669 - 6677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. J. TAEKEMA-ROELVINK, C. V. KOOTEN, S. V. D. KOOIJ, E. HEEMSKERK, and M. R. DAHA Proteinase 3 Enhances Endothelial Monocyte Chemoattractant Protein-1 Production and Induces Increased Adhesion of Neutrophils to Endothelial Cells by Upregulating Intercellular Cell Adhesion Molecule-1 J. Am. Soc. Nephrol., May 1, 2001; 12(5): 932 - 940. [Abstract] [Full Text]
|
|
|
|
|
|
Z. Khalkhali-Ellis, G. A. Bulla, L. S. Schlesinger, D. A. Kirschmann, T. L. Moore, and M. J. C. Hendrix C1q-Containing Immune Complexes Purified from Sera of Juvenile Rheumatoid Arthritis Patients Mediate IL-8 Production by Human Synoviocytes: Role of C1q Receptors J. Immunol., October 15, 1999; 163(8): 4612 - 4620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Goicoechea, A. W. Orr, M. A. Pallero, P. Eggleton, and J. E. Murphy-Ullrich Thrombospondin Mediates Focal Adhesion Disassembly through Interactions with Cell Surface Calreticulin J. Biol. Chem., November 10, 2000; 275(46): 36358 - 36368. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
